Cite
HARVARD Citation
Kato, T. et al. (n.d.). P-294Multicenter phase Ib/II study of biweekly TAS-102 with bevacizumab combination for patients with metastatic colorectal cancer refractory to standard therapies (BiTS study) - Trial in progress. Annals of oncology. p. . [Online].